Treatment with proteasome inhibitor bortezomib enhances antigen-specific CD8+ T-cell-mediated antitumor immunity induced by DNA vaccination

There is an urgent need to develop new innovative therapies for the control of cancer. Antigen-specific immunotherapy and the employment of proteasome inhibitors have emerged as two potentially plausible approaches for the control of cancer. In the current study, we explored the combination of the D...

Descripción completa

Detalles Bibliográficos
Autores principales: Tseng, Chih-Wen, Monie, Archana, Wu, Chao-Yi, Huang, Bruce, Wang, Mei-Cheng, Hung, Chien-Fu, Wu, T.-C.
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2008
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2535907/
https://www.ncbi.nlm.nih.gov/pubmed/18542898
http://dx.doi.org/10.1007/s00109-008-0370-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2535907/
https://www.ncbi.nlm.nih.gov/pubmed/18542898
http://dx.doi.org/10.1007/s00109-008-0370-y

Ejemplares similares